The Research Committee oversees and provides guidance for iCureCeliac® research-related activities, including:

  • Informing researchers about iCureCeliac® and encouraging them to develop studies using iCureCeliac® resources.
  • Facilitating engagement between researchers and iCureCeliac® members.
  • Informing network members about the research process and soliciting their input on iCureCeliac® research activities including individual studies.
  • Facilitating the development of new research studies based on topics of importance to the iCureCeliac®community.
  • Publishing and disseminating results from iCureCeliac® supported studies.
  • Providing review and approval of all research studies to be conducted through iCureCeliac®.

Daniel C. Adelman, MD

Research Chair

View bio

Daniel C. Adelman, MD, is Aimmunes’s Chief Medical Officer. As an allergist and immunologist, he has led drug development at biotechnology companies for more than 20 years and taught and practiced medicine at the University of California, San Francisco, for more than 25 years. Most recently, Dr. Adelman spent seven years as Chief Medical Officer and Senior Vice President of Development at Alvine Pharmaceuticals, a biopharmaceutical company focused on autoimmune and inflammatory diseases, particularly celiac disease. He held the same positions, as Chief Medical Officer and Senior Vice President of Development, during five years at Sunesis Pharmaceuticals, Inc. Earlier, Dr. Adelman served in various roles at Pharmacyclics, Inc., including Vice President of Clinical Operations and Biometrics, and was a Clinical Scientist at Genentech, Inc.

Dr. Adelman has published extensively in allergy, clinical immunology and autoimmunity, and oncology. He served on the Research Advisory Board of Food Allergy Research & Education (FARE) for more than five years and on the editorial board of the Journal of Allergy and Clinical Immunology for five years. He now serves on several clinical scientific advisory boards and on the editorial boards of Clinical Immunology and Journal of Clinical Immunology. Dr. Adelman holds a bachelor’s degree in biology from the University of California, Berkeley, and earned his MD from the University of California, Davis.

Sonia S. Kupfer, MD

View bio

Gastroenterologist Sonia Kupfer, MD, is a skilled specialist in all types of digestive system disorders. As a physician in the Comprehensive Cancer Risk and Prevention Clinic and the Celiac Center, she is particularly focused on diagnosing and treating patients with genetic disorders such as hereditary gastrointestinal cancer syndromes and celiac disease. She is currently Assistant Professor of Medicine at the University of Chicago Medical Center, Director of the Gastrointestinal Cancer Risk and Prevention Clinical, and Co-Director of the Comprehensive Cancer Risk and Prevention Clinic.

She has received funding from the National Institutes of Health/National Cancer Institute for studies of genetic associations in African-American colorectal cancer patients. She is an active member of the American Gastroenterological Association and the Collaborative Group of the Americas on Inherited Colorectal Cancer (CGA-ICC), and served as CGA-ICC President in 2016-17.

Benjamin Lebwohl, MD, MS

View bio

Dr. Lebwohl is a graduate of Harvard College, where he majored in music. He received his MD from Columbia College of Physicians and Surgeons in 2003, and then completed his internship, residency, and chief residency in internal medicine at Columbia.

He stayed at Columbia as a fellow in Digestive and Liver Disease, during which time he obtained a Masters in Patient Oriented Research from the Department of Biostatistics at the Mailman School of Public Health. Dr. Lebwohl is the Director of Clinical Research at the Celiac Disease Center at Columbia University, where he is collaborating with institutions in the United States and abroad in the areas of the epidemiology, patterns of care, and the natural history of celiac disease.

He is a prior recipient of the American Gastroenterology Association Research Scholar Award (2014-2017), studying the health effects of gluten in large cohort studies. He is an associated scholar at the Karolinska Institute in Stockholm, Sweden, where he performs population-based research in celiac disease in the Department of Medical Epidemiology and Biostatistics. He currently serves as a member of the Gastrointestinal Drugs Advisory Committee of the United States Food and Drug Administration. When he is not performing colonoscopy, Dr. Lebwohl plays cello in the St. Thomas Orchestra in Mamaroneck, New York.